Zhang Yingyu, Shi Ying, Wu Ruihong, Wang Xiaomei, Gao Xiuzhu, Niu Junqi
Department of Hepatology, The First Hospital of Jilin University, Changchun, Jilin, China.
Eur J Gastroenterol Hepatol. 2018 Jun;30(6):682-686. doi: 10.1097/MEG.0000000000001100.
The aim of this study was to evaluate the association between previous hepatitis B virus (HBV) infection and the severity of primary biliary cholangitis (PBC).
A total of 379 HBsAg-negative PBC patients were investigated between 2012 and 2017 in this study. Fifty-two of these patients underwent liver biopsy. The enrolled patients were divided into an anti-HBc-positive group and an anti-HBc-negative group; the patients with liver biopsy were further divided into early stage (stage I) and advanced stage (stages II, III, and IV) according to histological assessment. Liver fibrosis was also assessed by noninvasive prognosis scores including the Mayo Risk Score, the Newcastle model, the aspartate aminotransferase-to-platelet ratio index, the fibrosis index based on the four factors (FIB-4), and the albumin-bilirubin score. The difference in disease stage between the two groups was assessed by histological stage and noninvasive scores predicting fibrosis.
The histology showed that more patients in the anti-HBc-positive group had advanced stage compared with anti-HBc-negative patients (P<0.05). Higher Mayo Risk Score, the Newcastle model, aminotransferase-to-platelet ratio index, and fibrosis index based on the four factors (all P<0.05) were obtained in all patients except for the albumin-bilirubin score (P=0.096).
Previous HBV infection was associated with a worse histological stage and advanced fibrosis score of PBC. It appears that the previous HBV infection may have aggravated the PBC severity, potentially leading to poorer outcomes.
本研究旨在评估既往乙型肝炎病毒(HBV)感染与原发性胆汁性胆管炎(PBC)严重程度之间的关联。
本研究在2012年至2017年期间共调查了379例HBsAg阴性的PBC患者。其中52例患者接受了肝活检。将纳入的患者分为抗-HBc阳性组和抗-HBc阴性组;根据组织学评估,接受肝活检的患者进一步分为早期(I期)和晚期(II、III和IV期)。还通过非侵入性预后评分评估肝纤维化,包括梅奥风险评分、纽卡斯尔模型、天冬氨酸转氨酶与血小板比值指数、基于四项因子的纤维化指数(FIB-4)以及白蛋白-胆红素评分。通过组织学分期和预测纤维化的非侵入性评分评估两组之间疾病分期的差异。
组织学显示,与抗-HBc阴性患者相比,抗-HBc阳性组中处于晚期的患者更多(P<0.05)。除白蛋白-胆红素评分外(P=0.096),所有患者的梅奥风险评分、纽卡斯尔模型、天冬氨酸转氨酶与血小板比值指数以及基于四项因子的纤维化指数均更高(均P<0.05)。
既往HBV感染与PBC更差的组织学分期和更高的纤维化评分相关。既往HBV感染似乎可能加重了PBC的严重程度,可能导致更差的预后。